DAFNA Capital Management’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.48M | Sell |
|
|||||
|
2024
Q4 | $1.38M | Sell |
|
|||||
|
2024
Q3 | $1.41M | Hold |
|
|||||
|
2024
Q2 | $1.6M | Sell |
|
|||||
|
2024
Q1 | $3.08M | Sell |
|
|||||
|
2023
Q4 | $1.42M | Hold |
|
|||||
|
2023
Q3 | $1.52M | Hold |
|
|||||
|
2023
Q2 | $1.63M | Buy |
|
|||||
|
2023
Q1 | $471K | Hold |
|
|||||
|
2022
Q4 | $761K | Hold |
|
|||||
|
2022
Q3 | $944K | Hold |
|
|||||
|
2022
Q2 | $1.15M | Sell |
|
|||||
|
2022
Q1 | $1.66M | Hold |
|
|||||
|
2021
Q4 | $1.75M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $1.39M | Hold |
|
|||||
|
2016
Q2 | $1.22M | Buy |
|
|||||
|
2016
Q1 | $2.71M | Buy |
|
|||||
|
2015
Q4 | $785K | Hold |
|
|||||
|
2015
Q3 | $589K | Buy |
|